| Primary |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
14.4% |
| Urinary Tract Infection |
6.5% |
| Infection |
5.7% |
| Helicobacter Infection |
4.3% |
| Tooth Infection |
4.3% |
| Tooth Abscess |
3.7% |
| Vaginitis Bacterial |
3.7% |
| Pneumonia |
3.5% |
| Rosacea |
3.4% |
| Pain |
3.4% |
| Clostridial Infection |
3.1% |
| Diverticulitis |
3.1% |
| Hypertension |
3.1% |
| Brain Abscess |
2.7% |
| Clostridium Difficile Colitis |
2.6% |
| Liver Abscess |
2.4% |
| Diarrhoea |
2.2% |
| Vaginal Infection |
2.2% |
| Crohn's Disease |
2.2% |
|
| Vomiting |
12.9% |
| Toxic Encephalopathy |
10.7% |
| Encephalopathy |
8.7% |
| Urticaria |
7.5% |
| Paraesthesia |
6.3% |
| Anaphylactic Reaction |
4.6% |
| Drug Ineffective |
4.6% |
| Neuropathy Peripheral |
4.4% |
| Rash |
4.4% |
| Neurotoxicity |
4.0% |
| Psychotic Disorder |
3.6% |
| Vertigo |
3.6% |
| Stevens-johnson Syndrome |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Somnolence |
3.2% |
| Dysarthria |
3.0% |
| Clostridium Difficile Colitis |
2.8% |
| Drug Interaction |
2.8% |
| Nausea |
2.8% |
| Toxicity To Various Agents |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
31.6% |
| Drug Use For Unknown Indication |
17.3% |
| Helicobacter Infection |
5.3% |
| Drug Abuse |
5.3% |
| Pneumonia |
4.6% |
| Abdominal Infection |
3.4% |
| Hypertension |
3.2% |
| Pain |
3.0% |
| Sepsis |
2.8% |
| Prophylaxis |
2.8% |
| Urinary Tract Infection |
2.7% |
| Neoplasm |
2.5% |
| Infection |
2.4% |
| Antibiotic Prophylaxis |
2.1% |
| Cellulitis |
2.1% |
| Diverticulitis |
1.9% |
| Oedema |
1.8% |
| Acute Myeloid Leukaemia |
1.8% |
| Pyrexia |
1.8% |
| Abscess |
1.6% |
|
| Vomiting |
15.9% |
| Death |
7.4% |
| Swollen Tongue |
6.0% |
| White Blood Cell Count Increased |
5.1% |
| Clostridium Difficile Colitis |
4.9% |
| Thrombocytopenia |
4.9% |
| International Normalised Ratio Increased |
4.7% |
| Renal Failure Chronic |
4.7% |
| Toxic Epidermal Necrolysis |
4.7% |
| Pyrexia |
4.5% |
| Weight Decreased |
4.5% |
| Toxic Encephalopathy |
4.3% |
| Metabolic Acidosis |
4.0% |
| Encephalopathy |
3.8% |
| Myocardial Infarction |
3.8% |
| Stevens-johnson Syndrome |
3.6% |
| Drug Ineffective |
3.4% |
| Neutropenic Sepsis |
3.4% |
| Urticaria |
3.4% |
| Delirium |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.2% |
| Drug Use For Unknown Indication |
18.5% |
| Crohn's Disease |
7.3% |
| Pain |
5.7% |
| Hypertension |
4.4% |
| Prophylaxis |
4.2% |
| Infection |
3.2% |
| Diffuse Large B-cell Lymphoma |
2.4% |
| Depression |
2.4% |
| Nausea |
2.2% |
| Contraception |
2.0% |
| Constipation |
1.7% |
| Hiv Infection |
1.6% |
| Acute Myeloid Leukaemia |
1.6% |
| Multiple Myeloma |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Pneumonia |
1.4% |
| Sepsis |
1.4% |
| Breast Cancer |
1.4% |
| Diarrhoea |
1.3% |
|
| Vomiting |
14.3% |
| Weight Decreased |
10.8% |
| Sepsis |
8.4% |
| Pulmonary Embolism |
7.9% |
| Crohn's Disease |
5.8% |
| Pain |
5.1% |
| Thrombocytopenia |
4.8% |
| Septic Shock |
4.2% |
| Pyrexia |
4.0% |
| Renal Failure Acute |
3.9% |
| Renal Failure |
3.6% |
| Weight Increased |
3.6% |
| Death |
3.3% |
| Urinary Tract Infection |
3.1% |
| Nausea |
3.0% |
| Respiratory Failure |
3.0% |
| White Blood Cell Count Increased |
2.9% |
| Deep Vein Thrombosis |
2.8% |
| Tremor |
2.7% |
| Abdominal Pain |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
24.8% |
| Hypertension |
11.7% |
| Periorbital Cellulitis |
9.2% |
| Drug Use For Unknown Indication |
7.8% |
| Chest Pain |
4.6% |
| Pulmonary Embolism |
4.1% |
| Urinary Tract Infection |
4.1% |
| Depression |
3.9% |
| Diverticulitis |
3.4% |
| Psoriasis |
3.4% |
| Tooth Disorder |
3.0% |
| Torsade De Pointes |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Haematoma Infection |
2.5% |
| Cellulitis |
2.1% |
| Chalazion |
2.1% |
| Lung Disorder |
1.8% |
| Pneumonia |
1.8% |
| Urosepsis |
1.8% |
| Prophylaxis |
1.6% |
|
| Drug Interaction |
15.3% |
| Pyrexia |
12.5% |
| Clostridium Difficile Colitis |
8.3% |
| Vomiting |
8.3% |
| International Normalised Ratio Increased |
6.9% |
| Intraocular Pressure Increased |
6.9% |
| Toxicity To Various Agents |
5.6% |
| Hypotension |
4.2% |
| Malaise |
4.2% |
| Overdose |
4.2% |
| Convulsion |
2.8% |
| Drug Toxicity |
2.8% |
| Dysgeusia |
2.8% |
| Hypoglycaemia |
2.8% |
| Memory Impairment |
2.8% |
| Osmotic Demyelination Syndrome |
2.8% |
| Torsade De Pointes |
2.8% |
| Cholestasis |
1.4% |
| Electrocardiogram Qt Prolonged |
1.4% |
| Feeling Hot |
1.4% |
|
